Literature DB >> 1707731

Reduction of neurotensin immunoreactivity in the amygdala in Alzheimer's disease.

W C Benzing1, E J Mufson, L Jennes, D M Armstrong.   

Abstract

The density of neurotensin immunoreactivity (NT-IR) was dramatically decreased in 6 of 12 amygdaloid nuclear subregions in patients with Alzheimer's disease (AD) compared to age-matched normals. Diminution of NT-IR was most pronounced in amygdaloid regions containing the greatest number of senile plaques. This contrasts to our previous findings of little, if any, loss of substance P or somatostatin immunoreactivity within these same regions. The present findings corroborate biochemical reports of a decrease in NT-IR in the AD amygdala and suggest that this peptide may be selectively affected relative to other neuropeptides.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1707731     DOI: 10.1016/0006-8993(90)90372-i

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  3 in total

1.  Bee Pollen and Probiotics May Alter Brain Neuropeptide Levels in a Rodent Model of Autism Spectrum Disorders.

Authors:  Mashael A Alghamdi; Laila Al-Ayadhi; Wail M Hassan; Ramesa Shafi Bhat; Mona A Alonazi; Afaf El-Ansary
Journal:  Metabolites       Date:  2022-06-18

2.  Dissecting the role of sortilin receptor signaling in neurodegeneration induced by NGF deprivation.

Authors:  Simona Capsoni; Gianluca Amato; Domenico Vignone; Chiara Criscuolo; Anders Nykjaer; Antonino Cattaneo
Journal:  Biochem Biophys Res Commun       Date:  2013-01-11       Impact factor: 3.575

Review 3.  Neuropeptides Exert Neuroprotective Effects in Alzheimer's Disease.

Authors:  Xin-Yi Chen; Yi-Feng Du; Lei Chen
Journal:  Front Mol Neurosci       Date:  2019-01-11       Impact factor: 5.639

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.